CARE™ Guidance

CARE™ Management Considerations for Chronic Lymphocytic Leukemia (CLL) in 2019


28 May 2019

Members of the CARE™ Hematology Faculty held a working group meeting in conjunction with the CARE™ Winter Hematology Update on February 8th in Toronto. During this meeting, relevant news and data were considered in the area of chronic lymphocytic leukemia (CLL).

Direction for the meeting was informed by practice changing data from 2018 and access updates.

Topics of discussion included:

  1. Evolving standards in front-line CLL.

  2. Updates in R/R CLL.

  3. Integration of prognostic testing in clinical practice.

  4. Promising agents, combinations and trials to look out for in 2019.

What follows is a summary of select CARE™ Faculty discussions from the CARE™ CLL Working Group Meeting, along with guidance for managing CLL patients in Canada.